Successful perinatal management of hydrops fetalis due to hemolytic disease associated with D-- maternal phenotype.
We report the successful management of a case of hemolytic disease and hydrops fetalis secondary to anti Rh 17 antibodies in a woman with the rare D-- phenotype. We discuss the efficacy of intravenous immunoglobulins in treating hemolytic disease of the newborn infant.
Aref
K
K
Department of Pediatrics, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA.
Boctor
F N
FN
Pande
S
S
Uehlinger
J
J
Manning
F
F
Eglowstein
M
M
Mallozzi
A
A
Bebbington
M
M
Weinberg
G
G
Rosen
O
O
Raab
C
C
Brion
L P
LP
D000328:Adult; D004899:Erythroblastosis, Fetal / Q000209:etiology* / Q000235:genetics* / Q000628:therapy; D005260:Female; D006801:Humans; D015160:Hydrops Fetalis / Q000209:etiology* / Q000235:genetics* / Q000628:therapy; D007231:Infant, Newborn; D010641:Phenotype; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System / Q000009:adverse effects* / Q000235:genetics*
D012204:Rh-Hr Blood-Group System; C026410:Rho(D) antigen